Zyvox

Type: Product
Name: Zyvox
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Pfizer net earnings dips by 79% in Q2 to $2,912 million

Pfizer Inc, a second largest pharmaceutical company in the world after Novartis, has suffered heavy setback during the second quarter ended June 2014 on account of one time income received from sell of animal health business, Zoetis Inc.,  for a consideration ... [Published PharmaBiz - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 30 2014 - 1 reports

Earnings at Pfizer tank but still just beat expectations

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer (NYSE: PFE) posted a massive 79.4% drop in second-quarter 2014 earnings.Earnings plunged to $2.91 billion, or $0.45 per share, minus 77.3%, compared with $14.1 ... [Published Pharma Letter - Jul 29 2014]
Entities: Pfizer Inc, Prevnar, Enbrel
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Hypoglycemia and Linezolid

A small number of incidents have shown that linezolid, an antibiotic, may have an association with hypoglycemia....A small number of incidents have shown that linezolid, an antibiotic, may have an association with hypoglycemia....Linezolid (Zyvox) belongs ... [Published Diabetes in Control - Jul 26 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Novel Antibiotics for Skin and Soft Tissue Infection

Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589–1596.Dryden MS, Cooke J, Davey P. Antibiotic stewardship: ... [Published Diabetes Care - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Methicillin-Susceptible Staphylococcus Aureus Market Analysis and Segment Forecast to 2019

Methicillin-susceptible staphylococcus aureus (MSSA) infections are the infections caused by gram-positive bacterium. Staphylococcus aureus is the common pathogen in the skin, bone, central nervous system, pulmonary and soft tissues. These bacteria produce ... [Published MyNewsDesk - Jul 21 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Linezolid: Affordable generic access win highlights obstacles to life-saving treatment

With side effects that include stomach pain, vision problems, vomiting, diarrhea,  and anemia as well as pain, weakness, and numbness in hands and feet, linezolid is not something you would take if you had much choice.But for patients in Khayelishta, ... [Published NextBillion.net - Jul 07 2014]
First reported Jul 06 2014 - Updated Jul 06 2014 - 1 reports

New TB drug to be rolled out

CAPE TOWN - A cheaper version of a life-saving drug to treat drug-resistant TB will now be available in South Africa.Doctors Without Borders has been granted special access to a generic antibiotic for a fraction of the price.But for now, only a handful ... [Published ENCA - Jul 06 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Affordable drug-resistant TB medication still out of reach for many

CAPE TOWN - A cheaper version of a lifesaving drug to treat drug resistant TB will now be available in South Africa but only for a few patients.Doctors without Borders has been granted special access to a generic of a powerful antibiotic that costs more ... [Published ENCA - Jul 02 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Breakthrough TB treatment for SA

This is a victory for those suffering from the disease as it expands access to medicine that provides better treatment options, Medecins Sans Frontieres (MSF) (Doctors Without Borders) said, when announcing the drug yesterday.The antibiotic Linezolid ... [Published Citizen.co.za - Jul 02 2014]
First reported Jun 23 2014 - Updated Jun 24 2014 - 2 reports

FDA Approves Another New Antibiotic

FLICKR, THEGLOBALPANORAMAA new antibacterial drug to treat acute skin infections was approved for clinical use by the US Food and Drug Administration (FDA) last week (June 20). The drug, known as Sivextro or tedizolid phosphate, is approved for intravenous ... [Published The Scientist - Jun 24 2014]
First reported Jun 23 2014 - Updated Jun 24 2014 - 1 reports

Cubist and Durata Heat Up Antibiotic Market

Antibiotics are on a comeback. And Cubist Pharmaceuticals ( NASDAQ: CBST     ) is in the middle of it.Gone are the days when it seemed the Food and Drug Administration had a bone to pick with every antibiotic drugmaker. On Friday, the agency approved ... [Published Motley Fool Discussion Boards - Jun 23 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 2 reports

Cubist's Trius buyout pays off with FDA nod on high-powered antibiotic Sivextro

Less than a year after Cubist ($CBST) scooped up Trius for $707 million in a bid to boost its presence in antibiotics, it can boast an FDA approval out of the deal. On Friday, the agency approved Sivextro, an antibacterial drug to treat a range of skin ... [Published FiercePharma - Jun 23 2014]

Quotes

"So therefore we’d be able to greatly expand access to the number of patients in Khayelitsha.”"
...Department of TradeDepartment of Trade and Industry has been leading a six-year process to amend the country's intellectual property (IP) laws. "Reforms to South Africa's IP laws would help control medicine costs by preventing abusive patent monopolies, but a national policy has yet to be finalised or implemented. MSF urges rapid finalisation of a national IP policy that promotes access to affordable medicines, so lengthy battles like the one for generic linezolid will not repeat for other lifesaving drugs" says Julia Hill, MSF Access Advocacy Officer
..."MRSA is still problematic in the U S and is responsible for the deaths of more than 11,000 Americans each year," Corey said. "A six-day course of therapy with the option to choose--and, if needed--change from I V to oral administration is a welcome new development."
"We want responsible use of antibiotics," he said. "We're not the kind of company that goes out and puts these drugs in people's hands and says use them. They should only be used in patients with the highest medical need and used at right dose and duration."

More Content

All (41) | News (37) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Pfizer net earnings dips by 79% in Q2 to $2,912... [Published PharmaBiz - Jul 30 2014]
Pfizer Inc (NYSE:PFE) | Pfizer Announces Positi... [Published Jutia Group - Jul 29 2014]
Earnings at Pfizer tank but still just beat exp... [Published Pharma Letter - Jul 29 2014]
Tedizolid: A New Oxazolidinone -- Shorter and G... [Published WebMD - Jul 28 2014]
Pfizer Inc. (PFE) Q2 Earnings Preview: A Penny ... [Published I Stock Analyst - Jul 28 2014]
Hypoglycemia and Linezolid [Published Diabetes in Control - Jul 26 2014]
Pfizer's Incoming Patent Cliff [Published Motley Fool - Jul 24 2014]
Tedizolid: A New Oxazolidinone -- Shorter and G... [Published Diabetes Care - Jul 24 2014]
Cubist Misses Q2 Earnings Estimates on Weak Cub... [Published Zacks.com - Jul 23 2014]
Methicillin-Resistant Staphylococcus Aureus (MR... [Published MyNewsDesk - Jul 22 2014]
belladonna and opium (B and O Suppositories) [Published MedicineNet.com - Jul 22 2014]
Novel Antibiotics for Skin and Soft Tissue Infe... [Published Diabetes Care - Jul 22 2014]
Methicillin-Susceptible Staphylococcus Aureus M... [Published MyNewsDesk - Jul 21 2014]
Ted Rall: Moths to Flame [Published River Cities Reader - Jul 16 2014]
Where to buy Viagra dosages online - daynighthe... [Published Pressbox.co.uk - Jul 12 2014]
Hypoglycemia a possible adverse reaction to lin... [Published Orthopedics Today - Jul 11 2014]
Variability of linezolid concentrations after s... [Published 7thSpace - Jul 10 2014]
venlafaxine, Effexor; Effexor XR [Published MedicineNet.com - Jul 08 2014]
Linezolid: Affordable generic access win highli... [Published NextBillion.net - Jul 07 2014]
Growing Concern over the Efficacy of Vancomycin... [Published BusinessWeek - Jul 07 2014]
Ted Rall: We, the Corporations [Published River Cities Reader - Jul 06 2014]
New TB drug to be rolled out [Published ENCA - Jul 06 2014]
Affordable drug-resistant TB medication still o... [Published ENCA - Jul 02 2014]
Breakthrough TB treatment for SA [Published Citizen.co.za - Jul 02 2014]
More MSF patients with DR-TB gain access to dra... [Published FiercePharma - Jul 01 2014]
dobutamine (injection; Dobutrex) [Published MedicineNet.com - Jun 27 2014]
Global antibacterial drugs market set to rise t... [Published Live-PR.com - Jun 26 2014]
FDA Approves Another New Antibiotic [Published The Scientist - Jun 24 2014]
Cubist and Durata Heat Up Antibiotic Market [Published Motley Fool Discussion Boards - Jun 23 2014]
Medical Director, US Anti-Infectives [Published PharmaDiversity - Jun 23 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
7 Companies That Attempted to Silence Whistlebl... [Published Wall St. Cheat Sheet - Jun 19 2014]
Source: http://www.flickr.com/photos/stevendepolo/ Names like Daniel Ellsworth, Edward Snowden, and Julian Assange have become forever etched in the American lexicon. These individuals, along with troves of others, have single-handedly been able ...
Will Pfizer Try Again for AstraZeneca? [Published Wall St. Cheat Sheet - May 21 2014]
Source: Getty Images There is a misconception among investors that Pfizer ( NYSE:PFE ) was only trying to acquire AstraZeneca ( NYSE:AZN ) to gain access to a country with a corporate tax rate of 21 percent, far lower than the 35 percent rate ...
Despite Generic Vancomycin's Continued Dominanc... [Published PR Newswire: Health - May 06 2014]
BURLINGTON, Mass., May 6, 2014 /PRNewswire/ -- Decision Resources Group finds that overall, infectious disease (ID) specialists and non-ID physicians (critical care and internal medicine specialists) prefer the branded agents Cubist's Cubicin (daptomycin) ...
1

Press Releases

sort by: Date | Relevance
Current MRSA Antibiotics Will Face Competition ... [Published PR Newswire - Nov 19 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.